All ears at Cochlear’s results meeting

Cochlear’s first-half result was affected by the September recall but the early signs are that it won’t be a disaster. James Greenhalgh reports.

The last detailed review of Cochlear (see Cocky Cochlear boosts payout on 21 Oct 11 (Hold – $56.97)) expressed two primary concerns regarding the product recall of the Nucleus 5 implant.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles